Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $176.19M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 9.7× SPDR Kensho Final Frontiers ETF's market cap, and SPDR Kensho Final Frontiers ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| NUVB | ROKT | |
|---|---|---|
Market Cap | $1.71B | $176.19M |
Volume | 5,448,712 | 34,479 |
Sector | Health | Sector/Thematic |
52-Week High | $9.54 | $136.68 |
52-Week Low | $3.41 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $1.30B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
